Mostrar el registro sencillo del ítem

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBEGAUD, Bernard
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDE GERMAY, Sybille
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorNOIZE, Pernelle
dc.date.accessioned2024-05-21T07:02:23Z
dc.date.available2024-05-21T07:02:23Z
dc.date.issued2023-09-01
dc.identifier.issn1958-5578en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/199940
dc.description.abstractEnAlthough it can be difficult to define who should be considered an elderly person, the population aged 65 and over is experiencing the fastest demographic expansion and will represent almost one billion inhabitants of the 2030 World. Drug use increases dramatically with age and the elderly population is, by far, the highest consumer of medicines, up to 10 times more than younger adults. This consumption is in many aspects inappropriate, unjustified or sub-optimal and associated with a huge number of adverse reactions, admissions in emergency units and attributable deaths. A good part of which could be prevented if basic rules of good prescription and ad-hoc guidelines were systematically used. Even if older adults are more likely to present an adverse drug reaction, available data tend to support that the main risk factor of iatrogenesis in the elderly is the number of drugs used. Moreover, it is often irrelevant to transpose to this population the conclusions concerning the benefit-risk balance of drugs assessed in younger adults; similarly, approaches and programs classically used in pharmacovigilance and pharmacoepidemiology should be tailored to this specific population.
dc.language.isoENen_US
dc.subject.enAdverse drug reactions
dc.subject.enElderly
dc.subject.enPharmacoepidemiology
dc.subject.enPrescribing
dc.title.enDrugs and the elderly: A complex interaction
dc.title.alternativeTherapieen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.therap.2023.01.003en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed36841650en_US
bordeaux.journalTherapiesen_US
bordeaux.page559-563en_US
bordeaux.volume78en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue5en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamAHEAD_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-04580915
hal.version1
hal.date.transferred2024-05-21T07:02:25Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Therapies&rft.date=2023-09-01&rft.volume=78&rft.issue=5&rft.spage=559-563&rft.epage=559-563&rft.eissn=1958-5578&rft.issn=1958-5578&rft.au=BEGAUD,%20Bernard&DE%20GERMAY,%20Sybille&NOIZE,%20Pernelle&rft.genre=article


Archivos en el ítem

ArchivosTamañoFormatoVer

No hay archivos asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem